Targeting HSF1 sensitizes cancer cells to HSP90 inhibition

被引：54

作者：

Chen, Yaoyu ^{[1
]}

Chen, Jinyun ^{[1
]}

Loo, Alice ^{[1
]}

Jaeger, Savina ^{[1
]}

Bagdasarian, Linda ^{[1
]}

Yu, Jianjun ^{[2
]}

Chung, Franklin ^{[1
]}

Korn, Joshua ^{[1
]}

Ruddy, David ^{[1
]}

Guo, Ribo ^{[1
]}

Mclaughlin, Margaret E. ^{[1
]}

Feng, Fei ^{[1
]}

Zhu, Ping ^{[1
]}

Stegmeier, Frank ^{[1
]}

Pagliarini, Raymond ^{[1
]}

Porter, Dale ^{[1
]}

Zhou, Wenlai ^{[1
]}

机构：

[1] Novartis Inst Biomed Res, Cambridge, MA USA

[2] Novartis Inst Biomed Res, Emeryville, CA USA

来源：

ONCOTARGET | 2013年 / 4卷 / 06期

关键词：

HSF1; cancer cells; HSP90; inhibitor; Melanoma; HCC; DEDD2; SHOCK-PROTEIN; 90; HEAT-SHOCK; FACTOR-1; PROTEASOME; INDUCTION; COMPLEX; DEDD2;

D O I：

10.18632/oncotarget.991

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

The molecular chaperone heat shock protein 90 (HSP90) facilitates the appropriate folding of various oncogenic proteins and is necessary for the survival of some cancer cells. HSP90 is therefore an attractive drug target, but the efficacy of HSP90 inhibitor may be limited by HSP90 inhibition induced feedback mechanisms. Through pooled RNA interference screens, we identified that heat shock factor 1(HSF1) is a sensitizer of HSP90 inhibitor. A striking combinational effect was observed when HSF1 knockdown plus with HSP90 inhibitors treatment in various cancer cell lines and tumor mouse models. Interestingly, HSF1 is highly expressed in hepatocellular carcinoma (HCC) patient samples and HCC is sensitive to combinational treatment, indicating a potential indication for the combinational treatment. To understand the mechanism of the combinational effect, we identified that a HSF1-target gene DEDD2 is involved in attenuating the effect of HSP90 inhibitors. Thus, the transcriptional activities of HSF1 induced by HSP90 inhibitors provide a feedback mechanism of limiting the HSP90 inhibitor's activity, and targeting HSF1 may provide a new avenue to enhance HSP90 inhibitors activity in human cancers.

引用

页码：816 / 829

页数：14

共 42 条

[1]

DEDD and DEDD2 associate with caspase-8/10 and signal cell death [J].

Alcivar, A ;

Hu, SM ;

Tang, J ;

Yang, XL .

ONCOGENE, 2003, 22 (02) :291-297

[2]

Bagatell R, 2000, CLIN CANCER RES, V6, P3312

[3]

Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function [J].

Basso, AD ;

Solit, DB ;

Chiosis, G ;

Giri, B ;

Tsichlis, P ;

Rosen, N .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (42) :39858-39866

[4]

BAG3 and friends Co-chaperones in selective autophagy during aging and disease [J].

Behl, Christian .

AUTOPHAGY, 2011, 7 (07) :795-798

[5]

Beliakoff J, 2003, CLIN CANCER RES, V9, P4961

[6]

Targeting Heat Shock Protein 90 with Non-Quinone Inhibitors: A Novel Chemotherapeutic Approach in Human Hepatocellular Carcinoma [J].

Breinig, Marco ;

Caldas-Lopes, Eloisi ;

Goeppert, Benjamin ;

Malz, Mona ;

Rieker, Ralf ;

Bergmann, Frank ;

Schirmacher, Peter ;

Mayer, Matthias ;

Chiosis, Gabriela ;

Kern, Michael Andre .

HEPATOLOGY, 2009, 50 (01) :102-112

[7]

4,5-diarylisoxazole HSP90 chaperone inhibitors: Potential therapeutic agents for the treatment of cancer [J].

Brough, Paul A. ;

Aherne, Wynne ;

Barril, Xavier ;

Borgognoni, Jenifer ;

Boxall, Kathy ;

Cansfield, Julie E. ;

Cheung, Kwai-Miny J. ;

Collins, Ian ;

Davies, Nicholas G. M. ;

Drysdale, Martin J. ;

Dymock, Brian ;

Eccles, Suzanne A. ;

Finch, Harry ;

Fink, Alexandra ;

Hayes, Angela ;

Howes, Robert ;

Hubbard, Roderick E. ;

James, Karen ;

Jordan, Allan M. ;

Lockie, Andrea ;

Martins, Vanessa ;

Massey, Andrew ;

Matthews, Thomas P. ;

McDonald, Edward ;

Northfield, Christopher J. ;

Pearl, Laurence H. ;

Prodromou, Chrisostomos ;

Ray, Stuart ;

Raynaud, Florence I. ;

Roughley, Stephen D. ;

Sharp, Swee Y. ;

Surgenor, Allan ;

Walmsley, D. Lee ;

Webb, Paul ;

Wood, Mike ;

Workman, Paul ;

Wrightt, Lisa .

JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (02) :196-218

[8]

Inhibitors of HSP90 block p95-HER2 signaling in Trastuzumab-resistant tumors and suppress their growth [J].

Chandarlapaty, S. ;

Scaltriti, M. ;

Angelini, P. ;

Ye, Q. ;

Guzman, M. ;

Hudis, C. A. ;

Norton, L. ;

Solit, D. B. ;

Arribas, J. ;

Baselga, J. ;

Rosen, N. .

ONCOGENE, 2010, 29 (03) :325-334

[9]

Conde R, 2009, BIOCHEM CELL BIOL, V87, P845, DOI [10.1139/O09-049, 10.1139/o09-049]

[10]

Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis [J].

Dai, Chengkai ;

Whitesell, Luke ;

Rogers, Arlin B. ;

Lindquist, Susan .

CELL, 2007, 130 (06) :1005-1018

← 1 2 3 4 5 →